140 results
DEFA14A
ITCI
Intra-Cellular Therapies Inc
29 Apr 24
Additional proxy soliciting materials
4:46pm
Statement
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
Definitive Proxy Statement
Definitive Additional Materials … materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
+ MMMMMM C 1234567890
8-K
EX-1.1
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Entry into a Material Definitive Agreement
5:25pm
, including those relating to the generation, storage, treatment, use, handling, transportation, Release or threat of Release of Hazardous Materials … or threat of Release of Hazardous Materials, and have no knowledge of any event or condition that would reasonably be expected to result in any
424B5
ITCI
Intra-Cellular Therapies Inc
18 Apr 24
Prospectus supplement for primary offering
5:23pm
of our third-party suppliers and manufacturers and our ability to obtain alternative sources of raw materials;
our ability to obtain additional financing … countries;
the performance of our third-party suppliers and manufacturers and our ability to obtain alternative sources of raw materials;
our ability
424B5
lycfl
16 Apr 24
Prospectus supplement for primary offering
4:37pm
S-3ASR
EX-4.11
mfxkry1n57c
16 Apr 24
Automatic shelf registration
4:01pm
S-3ASR
4qf3p4sow4v5b3wc
16 Apr 24
Automatic shelf registration
4:01pm
S-3ASR
EX-4.10
snmw0zx2rkia
16 Apr 24
Automatic shelf registration
4:01pm
DEFA14A
23qb xguc
28 Apr 23
Additional proxy soliciting materials
4:42pm
8-K
EX-10.1
4qhvxdcqjrwgy0t46in
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
DEFA14A
tzvqsc29 2vsvzakc1g2
21 Apr 22
Additional proxy soliciting materials
5:04pm